Epicor. ^ "Apax Partners Acquires Software Giants Epicor, Activant For Close To $2 Billion". TechCrunch. Retrieved 2022-08-22. ^ "Apax Partners To Merge Epicor, Activant". informationweek....
Business software maker Epicor this morning announced that it has agreed to be acquired by private equity firm Apax Partners. The transaction is valued at approximately $976 million. In a separate...
Epicor Software Corp. is a global business software vendor that sells ERP and other software to small and medium-sized businesses (SMBs) and large enterprises. Epicor supports a wide range of industries and vertical markets with industry-specific software. It has a strong presence in manufacturing and distribution and although Epicor sells across the spectrum of company sizes, it is largely known as a midmarket ERP vendor. Epicor provides an on-premises version of its ERP software, and a variety...
Private equity firm Apax Partners plans to acquire business-application makers Epicor Software and Activant Solutions and combine them into a single mid-market company with annual revenue of $825 million. The companies announced the deal Monday, launching the latest merger attempt among vendors providing enterprise resource planning systems. Lawson Software said last month that it had received an unsolicited bid from rival Infor. Apax said the combined purchases of Epicor and Activant is valued ...
Advanced ERP software curated to unique needs of your business. Implement faster. See ROI sooner. Streamlined growth. Explore industry-specific tools for efficiency & success.
KKR had agreed to buy Epicor in July 2016 from Apax Partners, with The Wall Street Journal reporting at the time for $3.3 billion, including debt. The WSJ reported over the weekend that KKR...
2011년 5월 아팍스파트너스가 인수해 에피코르 소프트웨어(Epicor Software Corporation)와 합병해 에피코르라는 이름을 사기업으로 유지했다. 어드밴스트 비즈니스 마이크로시스템스는 1984년에 설립된 또 다른 전임 기업이다. ABM은 MS-DOS용 회계 소프트웨어 제품군을 만들어 IBM과 합작해 플래티넘 시리즈로 마케팅했다. ABM은 플래티넘 라인을 다중 사용자 LAN 기반 환경을 위해 설계된 금융...
Automotive ; Building Supply ; Distribution ; Manufacturing ; Retail
What to Read Next ; First Novel Schizophrenia Treatment in Decades Gains FDA Approval ; Does Warren Buffett Know Something That We Don’t? ; Opinion: Kamala Harris’s Mistake: Believing in Her Own Hype